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Summary: A combined adsorption-gel filtration technique has been developed for the quantitation of the cortisol-bin-
ding capacity of transcortin: Endogenous steroids are removed from plasma by adsorption on uncoated charcoal.
Saturation of the "stripped" binding sites of transcortin is accomplished by equilibrating the sample with a definite
amount of labeled cortisol of low specific activity (0.1 ^Ci/^g). Transcortin-bound [4-14C]cortisol is isolated by gel
filtration over Sephadex G-50 at 4 °C and measured by liquid scintillation counting. The cortisol-binding capacity of
transcortin is calculated directly on the basis of the known specific activity of cortisol. The modification described
eliminates methodological disadvantages associated with the original gel filtration procedures, i. e. the possible inter-
ference of various endogenous steroids with cortisol binding to transcortin, and the necessity of fluorometric or colori-
metric determination of protein-bound cortisol. The values of the cortisol-binding capacity of transcortin in plasma
obteined by this simplified assay are in close agreement with results reported in the literature (mean ± S. D.): healthy
males 261 ± 23 Mg/1 of transcortin-bound cortisol (n = 13), healthy nonpregnant females 255 ± 31 Mg/1 (n = 15), and
pregnant females prior to delivery 560 ± 82 g/l (n = 12).
Kombinierte Adsorptions-Gelfiltrationstechnik zur Bestimmung der Cortisol-Bindungskapazität von Transcortin
Zusammenfassung: Eine kombinierte Adsorptions-Gelfiltrationstechnik zur Bestimmung der Transcortin-Bindungs-
kapazität für Cortisol (TC-BC) wird beschrieben. Das Verfahren besteht aus folgenden Schritten: Entfernung der endo-
genen Steroide aus dem Plasma durch Adsorption an Aktivkohle; Sättigung der Transcortin-Bindungsstellen mit einer
definierten Menge an [4-14C]Cortisol niedriger spezifischer Aktivität (0,1 / *)\ Isolierung der Transcortin-gebunde-
nen Cortisolfraktion durch Sephadex-G-50-Gelfiltration bei 4 °C; Bestimmung der Transcortin-gebundenen Radioakti-
vität mittels Flüssigkeitsszintillationsmessung; direkteTC-BC-Berechnung mit Hilfe der vorgegebenen spezifischen
Aktivität der Cortisolsättigungslösung. Das dargelegte Verfahren erfüllt die methodischen Zuverlässigkeitskriterien. Die
Einführung des Adsorptionsschrittes bringt gegenüber den Originalgelfiltrationstechniken wesentliche Verbesserungen
hinsichtlich Spezifität, Richtigkeit und Praktikabilität mit sich: Ausschluß einer potentiellen unspezifischen Cortisolver-
drängung von den Transcortin-Bindungsstellen in vitro durch konkurrierende endogene Steroide; Ermöglichung einer
Isotopenmeßtechnik zur quantitativen Endbestimmung anstelle der unzuverlässigen und aufwendigen kolorimetrischen
bzw. fluorometrischen Analyse des körpereigenen Cortisolspiegels. Die vereinfachte Methode entspricht in ihren Resul-
taten den aus der Literatur bekannten Werten. Die damit ermittelte Transcortin-Bindungskapazität betrug bei gesun-
den Männern 261 ± 23 % Transcortin-gebundenes Cortisol pro l Plasma (Mittelwert ± Standardabweichung; n = 13),
bei gesunden nichtgraviden Frauen 255 ±31 g/l (n = 15) und bei Frauen im 10. Schwangerschaftsmonat 560 ±82 ^g/1
(n =12).
Introduction
The development of pharmacological models to assess
the estrogenicity of contraceptive steroids in man still
represents an important objective of research in re-
productive biology. Transcortin (synonym: corti-
costeroid-binding globulin = CBG) has been shown to
be a most specific indicator of estrogenic activity
responding with a dose-correlated elevation of its
cortisol-binding capacity to estrogen administration
(1). This parameter therefore seems to be particularly
suited to serve as a bioassay facilitating quantitative
comparisons of the estrogenic potency of hormonal
substances in the human.
1) This work is taken from a dissertation submitted by
U. Schwartz to the Freie Universität Berlin (1973) in
fulfillment of the requirements for the degree of Doctor
of Medicine. Parts of this paper have been presented at
the Eighth Acta cndocrinologica Congress in Copenhagen,
July 4-8, 1971 (Acta Endocrinol. (Copenhagen), Suppl.
155(1971), 168).
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At present no simple technique is available that permits
the completely satisfactory determination of transcor-
tin activity. Numerous principles have been applied to
its measurement in blood: equilibrium dialysis (2), gel
filtration (3, 4), ultrafiltration (5), and paper electro-
phoresis (6) as well as immunologic (7), enzymatic (8),
and adsorption procedures (9). Isotopic gel filtration
belongs to the most widely used methods in transcor-
tin analysis. The information thus obtained on the
various parameters characterizing steroid-protein inter-
actions is limited to the quantisation of the cortisol
binding capacity of transcortin. In view of its con-
venience, gel filtration may be regarded as the prefer-
able technique for comparative clinical studies provided
that identical experimental conditions are rigorously
maintained (10, 11). However, certain methodological
disadvantages concerning reliability and practicability
are associated with the original gel filtration procedures:
1) the possible in-vitro-interference with cortisol bin-
ding to transcortin by other steroids of possibly
unknown structure and/or quantity; and
2) the necessity for the fluorometric or colorimetric
measurement,of protein-bound cortisol.
A modification was therefore developed based on the
elimination of steroids from plasma by adsorption
and subsequent saturation of the stripped binding
sites of transcortin with a definite amount of labeled
cortisol prior to gel filtration. In addition, data will
be presented on the incomplete dissociation of the
albumin-cortisol complex during column chromato-
graphy with Sephadex at 4 °C. In spite of the un-
specific residual cortisol binding to albumin, the re-




Except for Sephadex G-50 medium (Deutsche Pharmacia,
Frankfuit/M) and Norit-A charcoal (Serva, Heidelberg), all
reagents were purchased from E. Merck, Darmstadt (reagent-
grade). Organic solvents were redistilled prior to use.
Steroids
Crystalline cortisol was obtained from Schering AG (Berlin)
and used without further purification. [4-14CJ cortisol (specific
activity: 159 MCi/mg; radiochemical purity: 96%) was pur-
chased from The Radiochemical Centre (Amersham, England)
and purified once a month by thinlayer chromatography (sol-
vent system: chloroform/ethanol, volumes, 80 ml + 20 ml).
The steroids were stored in benzene/methanol (volumes, 90 ml
+ 10 ml) solutions at 4 °C.
Proteins
Crystalline human serum albumin was obtained from Behring-
. werke AG, Marburg/Lahn (RH 20; electrophoretic purity:
100%). 131I-labelled Albumin (specific activity: 25 /zCi/mg; radio·«
chemical purity: 98%) was purchased from Hoechst (Frankfurt/
M). The proteins were stored at 4 °C and used without further
purification.
Apparatus
included jacketed chromatography colums K 9/30 (Dt. Phar-
macia, Frankfurt/M); cooling device TK 64, ultrathermostat
HT 13, automatic fraction collector UltroRac LKB 7000, photo-
meter Uvicord II LKB 8300 A, LKB recorder 6520 H (all
purchased from Colora, Lorch/Württ).
Radioactivity
was measured in a Tri-Cairb liquid scintillation spectrometer
3380 (Packard, Frankfurt/M) using the scintjllation fluid




The cortisol binding capacity of transcortin was determined
in heparinized plasma samples. Subjects were 13 healthy male
adults, 15 healthy, nonpregnant female adults, 8 patients with
total gonadal insufficiency, 12 pregnant patients at the end of
the tenth lunar month, and 35 nonselected patients who had
taken oral contraceptives over periods ranging from one month
to five years. Samples were stored in a deep freezer at - 20 ° C
up to six months. After thawing fibrin clots were removed by
centrifugation.
Elimination of endogenous steroids
(stripping) was accomplished by a modification Of the method
described by Heyns et al. (9). 200 mg of uncoated charcoal
were added to 4 ml of test plasma. The mixture was shaken
mechanically in a water bath for 30 min at 46 ° C. The adsor-
bent was then removed by centrifugation (10 min at 4,000
r. p. m.) and subsequent filtration Over Schleicher & Schiill
paper No. 595. Both steps were carried out twice.
Saturation of transcortin binding sites
1.0 ml of a solution containing 0.200 juCi of [4-14C] cortisol
and 2.000 Mg of cortisol in benzene/methanol (volumes,
90 ml + 10 ml) was evaporated to dryness under a stream, of
nitrogen. The radioactivity (pCi) of an aliquot of the saturation
solution was always counted and used as a basis for the calcu-
lation of the cortisol binding capacity of transcortin. 2.0 ml of
stripped undiluted plasma were added to the remaining film
of dry cortisol. The sample was then allowed to equilibrate at
37 °C for 60 min. in a water bath with gentle shaking. Prior
to chromatography, the overloaded plasma was cooled at 4 °C
for at least one hour.
Isolation of transcortin-bound cortisol
Sephadex G-50 medium was suspended in phosphate buffer
(0.15 mol/1; pH 7.4). After elimination of fines from the gel,
a jacketed column (9 X 300 mm) was packed at room tempera-
ture to a height of 27 cm (bed volume corresponding to 1.7 g
of Sephadex). Prior to use, the column was equilibrated at
4 °C. 0.3 nil of test plasma saturated with cortisol was then
placed on the column and allowed to drain into the gel. This was
followed by two 0.5-ml washes with buffer before elution was
initiated at a flow rate of 1 ml per min. The eluate was collected
in 1-ml portions directly into trie counting vials. Identification
of the protein fraction was achieved by ultraviolet photometry
at 280 nm. 10 ml of scintillation fluid were added to those por,
tions showing less than 100% transmittance, and radioactivity
.was subsequently determined. After emergence of the void
volume (about 5 ml), which was discarded, the proteins and
protein-bound radioactivity were always found between
fractions 6 and 11. As a control procedure the next four 1-ml·
portions were also analyzed. In preliminary experiments, re-
covery of [4-14C] cortisol ranged between 98 and 100% (60 de-
terminations), while elution of plasma equilibrated with 131I-
labeUed albumin resulted in a protein recovery of 97% (2 deter-
minations). After each completed run, the column was washed
with 40 ml of buffer and then reused for another assay.
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Calculation of the Cortisol binding capacity of transcortin
By equilibrating the stripped plasma sample with cortisol in
excess of its binding capacity, the binding sites of transcortin
are saturated with the steroid. Since the specific activity of the
solution used in the overloading step is known, the measure of
C-carbon in the protein fraction is also a measure of the
amount of protein-bound cortisol. This in turn is a measure
of cortisol binding capacity of transcortin provided that the
albumin-cortisol complex dissociates completely during the
gel filtration procedure. Therefore, the cortisol binding capacity
of transcortin (Mg of transcortin-bound cortisol per 1 of plasma)
can be calculated directly by the following equation:
TC-BC = transcortin-bound pCi X 1/SA X C,
where transcortin-bound pCi is the radioactivity contained in
the protein eluate, 1/SA the reciprocal value of the specific
activity of the saturation solution (Mg of cortisol per pCi), and
C the factor necessary for conversion of Mg of cortisol bound
per sample volume (0.3 ml) to Mg bound per 1 of plasma.
Results
Elimination of endogenous steroids
Two stripping procedures were compared with regard
to their efficiency and practicability.
(A) Gel filtration, at 46 °C (4) of plasma saturated with
[4-14C] cortisol (overloading dose: 2 mg/1) reduced the
amount of labeled steroid eluted in the protein fraction
to very low values (recovery of protein-bound radio-
activity: 4.9 ± 1.3%;. n-4).
(B) In order to evaluate the adsorption technique ori-
ginally described by Heyns et al. (9) plasma saturated
with labeled cortisol (overloading dose: 2 mg/1) was
incubated with increasing amounts of powdered char-
coal at room temperature and at 46 °C, respectively.
Table 1 indicates that equilibration with 50 mg of Norit
A per 1 ml of plasma for 30 min at 46 °C results in
almost complete adsorption of [4-14C] cortisol
(recovery of radioactivity: 1.7%). An incubation period
of 30 min at 46 °C was adequate to bring about the
desired stripping effect (Norit-A concentration:
50 mg/ml): 14C-carbon recovery was reduced to 3.2%
after 5 min, it was lowered to 2.2% after 15 min and
reached a value of 1.7% after 30 min. Extending the
duration of incubation to 60 min did not improve
efficiency (recovery of labeled cortisol: 1.6%).
Tab. 1. Elimination of [4-14C] cortisol from plasma by adsorp-
tion onto charcoal: Dependence on Norit-A concen-



















Tab. 2. Indirect comparison of the efficiency of two stripping
methods.
Plasma Cortisol binding capacity of transcortin (Mg/1)



















Cortisol load in all experiments: 2000 Mg/U N 1-3 = plasma of
healthy males; P 1-3 = late pregnancy plasma.
Table 2 shows the results of an indirect comparison of
the two stripping methods. In six duplicate determi-
nations the cortisol binding capacity of transcortin was
determined by isotopic gel filtration at 4 °C after
removal of endogenous steroids from plasma by ad-
sorption on charcoal or gel filtration at 46 °C, respec-
tively (prior to the final chromatography, the depleted
samples had been saturated with 2 mg of labeled cortisol
per 1 of plasma). No significant differences were observed
indicating that full binding activity was retained regard-
less of the stripping procedure applied.
Due to its higher degree of practicability and relatively
better efficiency the adsorption technique was used
routinely for the elimination of steroids from plasma.
Nonspecific cortisol binding to albumin
The amount of cortisol necessary to saturate the
stripped binding sites of transcortin was analyzed
(Fig. 1). Both in normal and late pregnancy plasma we
observed a linear elevation of the cortisol binding
capacity values with increasing cortisol loads. Equili-
bration of human serum albumin (crystalline albumin
dissolved in phosphate buffer pH 7.4; 40 g/1) with
increasing amounts of labeled cortisol, followed by
column chromatography at 4 °C, also resulted in a
similar rise of radioactivity appearing in the protein
eluate, although it was of considerably lesser magni-
tude (Fig. 1). These data demonstrate the incomplete
1000 1500 2000 2500 3000 3500 4000
Cortisol load l/ig/l]
Duration of incubation in all experiments: 30 min
Fig. 1. Cortisol-binding capacity of plasma (x—χ normal;
A—4 late pregnancy) and purified albumin (40 g/1,
•—·): Dependence on cortisol load. 4 = routine
cortisol load.
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dissociation of the albumin-cortisol complex during gel
filtration at 4 °C. However, if one subtracts the non-
specific binding to albumin from the values obtained
with normal and late pregnancy plasma, it be- .
comes obvious that the mean levels of presumably trans-
cortin-bound cortisol do not change significantly
despite increasing overloading doses (Fig. 2). In order
to allow for sufficient saturation of the binding sites of
transcortin, while at the same time minimizing the resid-
ual cortisol binding to albumin, the cortisol load was
kept as low as 1 mg per 1 of plasma in the routine pro-
cedure.
Gel filtration at 4 °C of cortisol-saturated buffer solu-
tions containing varying amounts of purified albumin
(20, 40, and 80 g/1) showed that the extent of non-
specific binding to albumin under standard assay con-
ditions is only insignificantly enlarged by an increase
in albumin concentraction (Tab. 3). Likewise, the in-
Tab. 4. Cortisol binding capacity of transcortin of human
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Fig. 2. Cortisol binding to transcortin and albumin (a) late
pregnancy plasma; b) normal plasma): Dependence on
cortisol load. * = insufficient cortisol load; I = routine
cortisol load; hatched part of columns = transcortin-
bound cortisol; nonhatched part of columns = albumin-
bound cortisol; = mean value of transcortin-bound
cortisol.
Tab. 3. Cortisol binding to purified albumin: Dependence on























































Cortisol load in all experiments: 2000 Mg/1;
N = plasma of a healthy male;
P = Late pregnancy plasma
vitro-addition of crystalline albumin to plasma samples
caused no marked change of the cortisol-binding
capacity as determined by the combined adsorption-gel
filtration procedure (Tab. 4). In a further experiment,
transcortin of normal and mid-pregnancy plasma was
inactivated selectively and irreversibly by heating for
30 min at 60 °C (13) after elimination of endogenous
steroids. The samples were subsequently saturated and
then submitted to column chromatography at 4 °C.
Analysis of the protein-bound cortisol fraction indicated
that the extent of residual cortisol binding to albumin
is independent of transcortin levels: it amounted to
41 Mg/1 in a healthy male and to 39 Mg/1 in a pregnant
female at mid-term (cortisol binding capacity of trans-
cortin of the uriheated controls: 193 and 390 Mg/1,
respectively). In routine determinations of the cortisol
binding capacity of transcortin for comparative clinical
studies, the values obtained were not corrected for non-
specific binding to albumin.
Application to human plasma
Cortisol binding capacity of transcortin under phy- *
siological, pathological and contraceptive conditions
as measured by the present modification is illustrated
in Figure 3. The mean values were 261 ± 23 (S. D.)
Mg/1 in 13 healthy males, 255 ± 31 Mg/1 in 15 healthy
nonpregnant female adults, and 560 ± 82 Mg/1 in
12 pregnant females prior to delivery. Normal results
were obtained in 8 patients with total gonadal in-
sufficiency (241 ± 27 Mg/1). However, administration
of oral contraceptives over periods ranging from one
month to five years induced a highly significant in-
crease in the cortisol binding capacity (t-test for unpaired
variates: p < 0.001): 428 ± 53 jug/1 in 20 patients receiving
Ortho Novum 1/50 (Cilag-Chemie, Aisbach/Bergstra e;
50 μ% of mestranol + 1 mg of norethindr ne per day),
and 542 ± 64 /jg/1 in 15 patients taking Eugynon (Schering
AG, Berlin; 50 jug of ethinylestradiol + 0,5 mg of D, L-
norgestrel),
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n=13 n=15 n = 8 n«12 n=20 n=15
Tab. 5. Precision of the combined adsorption-gel filtration assay
a) Cortisol binding capacity of transcortin sixtuplicate
determinations of the same sample by or
Fig. 3. Cortisol binding capacity of transcortin under physio-
logical, pathological and contraceptive conditions (non-
selected patients on oral contraceptives for periods rang-
ing from 4 weeks to 5 years).
Sensitivity and precision
Figure 4 demonstrates the relative sensitivity of the
method described. Various volumes of phosphate
buffer pH 7.4 (1, 2, 3, and 4 ml) were added to assay
tubes, and the final volume was made up to 6 ml with
plasma of a healthy male. Duplicate determinations of
the cortisol binding capacity of transcortin were then
carried out with 0.3 ml aliquots of these plasma dilutions.
The assay proved to be linear over a threefold range
(r = 0.9992; p < 0.001).
For assessment of reproducibility, sixtuplicate deter·:
minations were performed by a single technician on
aliquots of identical material (normal and late preg-
nancy plasma, respectively) in a single day using the
same batches of reagents (within-assay variability) as
well as on six consecutive days using different batches
of reagents (between-assay variability). In addition, we
evaluated the between-technician variability by calcu-
lating the mean standard deviation of 89 nonselected
duplicate determinations run by two different operators
in the course of one year. Table 5 shows the high degree
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Ν = plasma of a healthy male; Ρ = late pregnancy plasma;
b) Cortisol binding capacity of transcortin duplicate




S. D. of duplicate determinations
(Mg/D
Technician A Technician B
200-300
400-600
± 1 0 ( n = 3 7 )
± 12(n = 30)
± 4 ( n = ll)
± 6 ( n = 10)
Discussion
Gel filtration is a generally accepted principle for the
isolation of transcortin-bound cortisol. As a nonequi-
librium procedure characterized by small, but continuous
dissociation of the transcortin-cortisol complex, it yields
submaximal values for the cortisol binding capacity of
transcortin. However, the dialysis effect can be reduced
to a negligible minimum by proper choice of tempera-
ture, pH, amount of Sephadex, column dimensions,
sample volume and elution rate. Provided that assay
conditions are strictly standardized and that the inter-
pretation of results is kept within its theoretical limits,
this technique represents a reliable and convenient
method especially suited for comparative clinical studies.
Two basic requirements for the validity of experimental
data obtained by the gel filtration procedure are
(A) that the cortisol binding capacity of transcortin
remains per definition unchanged after saturation of all
binding sites of transcortin is attained, and
(B) that the albumin-cortisol complex dissociates com-
pletely during Sephadex chromatography at 4 °C
because of its low association constant.
However, in disagreement with previous reports by De
Moor et al. (3) and Doe et al. (4), we noted that, de-
spite gel filtration at low temperature, a portion of
cortisol is bound to purified albumin depending on the
quantity of cortisol used in the overloading step. The
linear elevation of protein-bound cortisol observed
in plasma samples with rising cortisol loads may be
explained by this effect, since cortisol in excess of the
limited cortisol binding capacity of transcortin is bound
to albumin. The extent of nonspecific cortisol binding
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appeared to depend solely on the overloading dose.
It remained practically unaffected by increases in
plasma albumin, as shown by analysis of samples with
human serum albumin concentrations approaching
levels three times higher than the upper physiological
limit. When employing a cortisol load of 1 mg per 1 of
plasma, as in the routine procedure, the amount of
albumin-bound cortisol entering values of the cortisol
binding capacity of transcortin proved to be fairly
small and constant (approximately 40Mg/l). It is
suggested that this systematic error occurs with all
techniques utilizing nonsteady-state gel filtration. For
practical reasons we do not consider it essential in
comparative clinical studies to correct the individual
data for residual cortisol binding to albumin; however,
if a higher degree of specificity and accuracy is desired,
the exact magnitude of this systematic error can be
determined following selective heat inactivation of
transcortin (13).
Combining the Sephadex column procedure with an
adsorption technique improves the reliability and
practicability of the assay.
A major limitation of the original method regarding
specificity and accuracy orginates from the competition
of various endogenous steroids with cortisol for binding
sites on transcortin. It has been shown that progesterone
displaces cortisol from its specific binding protein
during pregnancy, thus causing an underestimation of
the true cortisol binding capacity of transcortin (10, 14).
Similar effects possibly induced e. g. by synthetic
progestins administered for contraceptive purposes
cannot be ruled out at present. Another disadvantage
associated with the original gel filtration technique
stems from the utilization of fluorometric or colon-
metric assays for the quantitation of protein-bound
cortisol. Application of either method may result in
an overestimation of the actual cortisol binding capa-
city of transcortin if nonspecific fluorescents or Porter-
Silber chromogens other than cortisol were present.
Substituting a competitive protein-binding assay for
these procedures should increase the degree of accu-
racy; however, it would still be rather time-consuming. .
The use of charcoal-treated samples saturated with a
definite amount of labeled cortisol prior to gel filtra-
tion not only eliminates the possible inhibition of
specific cortisol binding by other steroids, but also
permits the direct radioactive measurement of the
cortisol binding capacity of transcortin. The intro-
duction of the adsorption step provides for complete
removal of endogenous steroids from plasma without
damaging transcortin. Other stripping procedures seem
to be less or not at all suitable: Extraction with organic
solvents leads to an irreversible denaturation of trans-
cortin, whereas dialysis against bovine albumine at
40 °C fails to remove the endogenous steroids suffi-
ciently (15). Gel filtration at 46 °C (16; own experi-
ments) or at pH 5.0-5.5 (17) brings about the
desired stripping effect, yet it lacks the technical
simplicity of the adsorption technique.
The combined adsorption-gel filtration method meets
the reliability criteria defined byBorth (18), It proved
to be specific, since the isolated protein fraction exhib-
ited the same properties as transcortin (10): It bound
approximately 260 Mg of cortisol per 1 of plasma. No
difference was observed between healthy male and
ferrVale adults. Total gonadal insufficiency did not
Tab. 6. Estimates of the cortisol binding capacity of transcortin from the literature
Reference Method




Daughaday et al. (2)
Westphal (19)
Mills (5)
Keane et al. (20)
Osorio and Schats (6)
Leybold et al. (8)
Pegg ana Keane (21)
Trapp and West (22)
Pirke and Stamm (23)
De Moor et al. (3)
Murphy and Pattee (24)
Doe et al. (4)
Hoffmann and Westphal (16)
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result in reduced cortisol binding capacity of transcortin.
A significant elevation was found only in pregnancy
and after administration of estrogenic substances. The
binding protein measured also displayed the expected
temperature dependency: maximum values were
recorded at 4 °C, reversible inactivation was accom-
plished at 46 °C, while heating at 60 °C caused irrevers-
ible denaturation. The procedure was also shown to be
very accurate as our data are in close agreement with
estimates published in the literature (Tab. 6). In addi-
tion, results had a high degree of precision (Table 5),
and the relative sensitivity was quite satisfactory
(Fig. 4). The described method combines good relia-
bility with adequate practicability: it is simple to
learn, reproducibility is excellent even in the hands
of unskilled technicians, and 8 determinations can
easily be performed by one person per day.
Considering the elimination of methodological dis-
advantages associated with the original gel filtration
assay, the present modification seems to be a useful
addition to the techniques already available for the
quantitation of transcortin activity.
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